Login

FDA Grants Orphan Drug Designation to Cardiol Therapeutics' Lead Candidate for Recurrent Pericarditis| David Elsley, CEO, Cardiol Therapeutics Inc. 00:10:00

Share On Facebook Share On Twitter

Cardiol Therapeutics CEO David Elsley discusses the FDA's recent grant of Orphan Drug Designation for the company's lead small molecule drug candidate targeting pericarditis, emphasizing its potential to improve patients' quality of life. This milestone underscores the significance of CardiolRx in addressing a debilitating heart condition and highlights the company's commitment to advancing innovative therapies for cardiovascular diseases.

Recent Videos

00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

00:10:00
The Investor Perspective- From Start to Scale' with Caryn Marooney|Chetan Puttagunta,investor,Benchmark
00:10:00
In Conversation: Matt Brown & Blythe Masters on Finance Innovation and Blockchain
00:10:00
JSE-listed Aspen CEO Stephen Saad discusses the challenges of the pharmaceutical industry with CNBC Africa.
00:10:00
COVID's Impact on the Health Care Sector: Insights from Joe Abbott and Laura Mattern of Johnson Investment Counsel
00:10:00
Chinese Companies Consider Hong Kong Listings Amid US Disadvantages | Hao Hong, chief China strategist , Bank of Communications.
00:10:00
Empowering Communities: Lincoln Financial Foundation and Bunker Labs Initiatives
00:00:00
MicroBix (MBX.T) CEO, Cameron L. Groome, talks antigens
00:10:00
Tenable CEO Amit Yoran reports incredibly high demand for cybersecurity, as shared on CNBC Television.
00:10:00
Business of Biotech- Trends in Life Science Funding & Exits|Tim Shannon,General Partner,Canaan Partners
00:10:00
Mr. Nobuo Tanaka, former Executive Director of the International Energy Agency and CEO of Tanaka Global, delivered a special keynote address on energy and the environment on September 4, 2023.
00:10:00
$1.15 billion stake in its company to Sequoia and Paradigm in January 2022|Alfred Lin,Investor, Sequoia
00:10:00
Exploring New Gold Opportunities: Focus on the Witwatersrand and Australian Projects

© 2017 - Townhall + Tv